SX-682
A Phase 1, Open-Label, Dose-Escalation With Expansion Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
Arms / Cohorts
Experimental:Dose Escalation: SX-682
Accepting patients
Experimental:Dose Expansion: SX-682
Accepting patients
Experimental:Dose Expansion: SX-682
Accepting patients
Experimental:Dose Expansion: SX-682 + Decitabine
Accepting patients
Experimental:Dose Expansion: SX-682 + Decitabine
Accepting patients
Experimental:Dose Expansion: SX-682
Accepting patients
Experimental:Dose Expansion: SX-682 + Decitabine
Accepting patients
Experimental:Dose Expansion: SX-682 + Decitabine
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.